[Pubmed] Robotic Thymectomy for Myasthenia Gravis: Analysis of the Surgical and Neurological Outcomes After a 20 Years'

Intégration des publications parues sur PUBMED
Répondre
Avatar du membre

Auteur du sujet
RSS-Bot
Ami(e) de Diamant
Ami(e) de Diamant
Messages : 6512
Enregistré le : 31 mai 2020 09:57
6
Zodiaque :
Âge : 22
Contact :
    Linux Chrome

[Pubmed] Robotic Thymectomy for Myasthenia Gravis: Analysis of the Surgical and Neurological Outcomes After a 20 Years'

Message par RSS-Bot »


Eur J Neurol. 2025 Apr;32(4):e70147. doi: 10.1111/ene.70147.

ABSTRACT

BACKGROUND: Evidence supporting robotic thymectomy for myasthenia gravis is generally based on small sample-size studies, heterogeneous in patient selection and in reporting outcomes. Therefore, this study was conducted to assess the surgical and neurological outcomes of robotic thymectomy in myasthenic patients and to identify prognostic factors associated with symptoms' remission through a large cohort of patients operated in a 20 years' period.

METHODS: A retrospective analysis of a prospectively maintained database was conducted for all patients undergoing robotic thymectomy for myasthenia gravis between 2002 and 2022. Myasthenia Gravis Foundation of America (MGFA) recommendations were used to report the neurological outcomes. Complete remission and overall improvement were evaluated using Cumulative Incidence Functions, while the effect of preoperative variables on the probability of remission was estimated with Cox models.

RESULTS: In total, 267 patients underwent robotic thymectomy. Median operative time was 135 min and there were 7 (2.6%) open conversions. Clinical follow-up (median 83 months) showed a 5-year probability of complete remission of 18% and of overall improvement of 84%. Complete remission was negatively associated with age (HR 0.97, 95% CI 0.95-0.99, p = 0.001) and preoperative use of pyridostigmine (HR 0.34, 95% CI 0.15-0.81, p = 0.014), while severe MGFA class did not reach significance (HR 0.55, 95% CI 0.3-1.01, p = 0.052). Instead, there was a benefit in patients operated on in later years (HR 1.11, 95% CI 1.04-1.18, p = 0.01).

COMMENT: Robotic thymectomy is a safe procedure. Long-term neurological follow-up demonstrated an improvement in most patients, also in subgroups that historically showed worse outcomes.

PMID:40231756 | DOI:10.1111/ene.70147


Source: https://pubmed.ncbi.nlm.nih.gov/4023175 ... t9+e462414
Si vous appréciez notre travail, merci de nous soutenir un petit don en cliquant ICI

Pour obtenir la traduction en français,
cliquez sur le bouton situé dans la barre des menus en haut de cette page 

Image


Pour les donateurs, si cet article vous intéresse, nous pouvons faire l’acquisition d'un tiré-à-part.
Merci d'en faire la demande sur [email protected]


Bonne lecture...
Répondre

Retourner vers « Echos de la recherche »